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ABSTRACT Eighteen variants recovered from specific
locus mutation rate experiments involving the mutagen chlor-
ambucil were subjected to several genetic and molecular anal-
yses. Most mutations were found to be homozygous lethal.
Because lethality is often presumptive evidence for multilocus-
deletion events, 10 mutations were analyzed by Southern blot
analysis with probes at, or closely linked to, several of the
specific locus test markers, namely, albino (c), brown (b), and
dilute (d). All eight mutations {two c; three b; two d; and one
dilute-short ear [Df(d se)]} that arose in post-spermatogonial
germ cells were deleted for DNA sequences. No evidence for
deletion of two d-se region probes was obtained for the
remaining two d mutations that arose in stem-cell spermatogo-
nia. Six of the primary mutants also produced low litter sizes
("semisterility"). Karyotypic analysis has, to date, confirmed
the presence of reciprocal translocations in four of the six. The
high frequency of deletions and translocations among the
mutations induced in post-spermatogonial stages by chloram-
bucil, combined with its overall high efficiency in inducing
mutations in these stages, should make chlorambucil mutagen-
esis useful for generating experimentally valuable germ-line
deletions throughout the mouse genome.
Analysis of heritable mutations at the molecular and organ-
ismal levels can provide significant insights into the structural
and functional composition of the mammalian genome. Cer-
tain types of mutations, namely, chromosomal deletions,
translocations, and insertion-induced mutations, provide
useful experimental reagents for accessing, at the molecular
level, particular chromosomal segments or loci associated
with specific developmental phenotypes.
In humans, chromosomal deletions have proved especially
useful in the selection of DNA clones that map to genomic
subregions associated, for example, with muscular dystrophy
(1-3), chronic granulomatous disease (4), retinoblastoma (5,
6), and sex determination (7). In the mouse, analysis of
complexes of radiation-induced deletion mutations has facil-
itated the development of gross functional maps of segments
of the genome (8-11) and is currently providing reagents for
the development of fine-structure "point" mutation maps
(12) as well as for more detailed molecular maps. Conse-
quently, the exploitation of germ-line deletion mutations has
great potential for expanding our understanding of the func-
tional and physical composition of the mouse genome. How-
ever, most of the extant heritable deletion mutations of the
mouse have arisen over a period of decades in radiation-
mutagenesis experiments and are limited to genomic regions
including and surrounding recessive marker loci employed in
the mouse visible specific locus test (13, 14) and a few
dominant marker loci (15-17). Therefore, currently available
deletions cover only a small percentage of the genome.
The chemotherapeutic agent chlorambucil (CHL) can in-
duce, in certain germ-cell stages of male mice, heritable
specific locus mutations at frequencies perhaps as high as 1.3
X 10-3 mutations per locus per gamete (18). The highest
frequency of mutations is transmitted by sperm derived from
CHL-exposed early spermatids-i.e., in progeny sired during
the third week after CHL injection. Some of the mutations
recovered from these and other post-spermatogonial germ-
cell stages displayed genetic attributes usually associated
with chromosomal deletions and translocations (18). For
example, a variant was recovered that was simultaneously
mutant in d (dilute) and se (short ear), which are two closely
linked [0.16 centimorgan (cM)] loci, suggesting a deletion
event. Further, several lethal mutations were also identified
that, on the basis of earlier findings (8, 9, 19), could be
assumed to carry deletions of the marker locus along with
neighboring essential loci. Semisterility (low litter size) was
observed in several mutant lines, which is often indicative of
the segregation of a balanced translocation (20). Further-
more, direct cytogenetic analysis also detected a three-band
deletion of chromosome 4 in G-banded chromosome prepa-
rations derived from a b (brown) locus mutant as well as a
translocation in a c (albino) locus mutant line (18).
If the majority of post-spermatogonially induced CHL
mutations are indeed deletional in nature, this mutagenesis
protocol should be a highly efficient method for producing
germ-line deletion mutations in the mouse. We report here
further genetic and cytogenetic analysis of the set of specific
locus mutations that were recovered in the CHL-mutagenesis
experiments (18), and the initial molecular characterization of
10 of them (two c, three b, four d, and one d-se). Eight of
these 10 mutations were derived from CHL-exposed post-
gonial germ-cell stages and two were derived from exposed
stem-cell spermatogonia. We demonstrate that the 8 muta-
tions induced in postgonial stages are deleted for molecular
probes at, or closely linked to, the marker loci, thereby
confirming that CHL treatment of post-stem-cell stages does
indeed induce deletion mutations with high efficiency. We
also provide evidence that, in these same germ-cell stages,
CHL induces heritable reciprocal translocations.
MATERIALS AND METHODS
Mice. All mice were bred at Oak Ridge National Labora-
tory. Each mutation studied was recovered in the progeny of
CHL-treated (101/Rl x C3Hf/Rl)F1 wild-type males that had
been crossed to T-stock females of the genotype a/a; b/b; p
cch/p cch; d se/d se; s/s (18). The mutations, along with their
Abbreviations: CHL, chlorambucil; cM, centimorgan.
tTo whom reprint requests should be addressed.
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currently known characteristics, are listed in Table 1. Fetuses
produced from crosses of cch/C*l X Cch/C*2 heterozygotes
(where c*] and c*2 are any two mutations involving c) that
were compound heterozygotes for albino mutations were
identified at 14.5 days post coitum as those fetuses lacking
eye pigment.
Probes and Hybridization Protocols. The MTY811 tyrosi-
nase cDNA clone (21) was used as a probe for the c locus.
Clone 23.3, a 1.4-kilobase (kb) EcoRI-HaeIII fragment de-
rived from a region 5' to the site of integration of the Emv-23
endogenous ecotropic provirus (22), was used as an addi-
tional closely linked (<0.5 cM) molecular marker for c region
mutations. A 0.25-kb Pvu II fragment of the pMT4 clone (23)
was used as a specific probe for the b locus (24). For the d-se
region mutations, we employed clones pO.3, a 2.6-kb EcoRI-
Pst I fragment derived from the region 3' to the site of
integration of the d-associated provirus Emv-3 (10, 25), and
p94.1, a 0.5-kb EcoRI-HindIII fragment derived from the
proximal end of a 3.3-kb EcoRI deletion breakpoint/fusion
fragment carried in the dJ9RJ45H prenatal-lethal mutation (10).
High molecular weight DNA was obtained by standard
methods (26, 27) from distal tail-tip biopsies from either
primary mutants or their progeny. In certain instances,
spleen or fetal DNAs were analyzed from progeny of genetic
crosses involving specific CHL-induced mutations. Southern
blot analysis of genomic DNA was performed as described
(22), except that DNA was transferred to nylon in lOx SSC
(instead of alkali) and was crosslinked to the membrane by
exposure to UV (instead of baking). (lx SSC = 0.15 M
NaCI/0.015 M sodium citrate, pH 7.0.)
RESULTS
Genetic and Cytogenetic Analysis of CHL-Induced Muta-
tions. Each specific locus mutation (m*) is recovered in
heterozygosity with the corresponding recessive marker (m)'
contributed by the T stock. The primary mutants were
crossed with appropriate stocks to confirm allelism (18), and
subsequent crosses were made to generate homozygotes
(m*/m*) from each mutation. In cases where m/m* is
phenotypically distinguishable from m/m (e.g., cch/c* mu-
tants) or where the T stock supplies a linked marker (e.g., d
se/d* + mutants), appropriate heterozygotes to be mated for
the production ofhomozygotes can be directly identified, and
the absence of homozygotes among 30 or more of their
classified offspring was taken as evidence of prenatal lethal-
ity. In other cases (s/s* or b/b* mutants), lines that could be
either m/m or m*/m* were generated by outcrosses to wild
type, followed by an additional outcross and backcross; when
all of 12 such lines were viable, the mutation was provision-
ally classified as viable. [Assuming equal transmission of m*
and m, the probability that all 12 lines would be m/m by
chance is (0.5)12 or 2 x 10-4; this probability is, however,
greater if transmission of m* is reduced.] Homozygous
lethality/viability results are shown in Table 1, along with the
fertility status of animals heterozygous for the mutation.
Since production of a reduced number of offspring can be
indicative of gross chromosomal rearrangement (death of
chromosomally unbalanced segregants), mutants that pro-
duced low litter size were studied cytogenetically in Giemsa-
banded mitotic metaphase preparations from cultured kidney
fibroblasts (28). The results of this karyotypic analysis, which
Table 1. Heritable CHL-induced specific locus mutations used in this study
Viability/ Deletion detectable with probet
Germ-cell stage lethality of Fertility of
Mutation of origin homozygotes heterozygotes* Karyotype MTY811 23.3 MT4 0.3 94.1
bOR-7Q Spermatozoa S
bOR-IOQ Late spermatocytes Unknown F - Yes Not -
bOR-J9Q Spermatozoa TNC§ PF Del(4C1-C3) - Yes Not -
bOR-2IQ Early spermatids Lethal F - Yes Not -
cOR8Q Late spermatocytes Lethal FI T(5;?) Yes Yes
COR-15Q Early spermatids Lethal F Yes Yes
dOR-18Q Spermatozoa Lethal SS T(3;6)- Not No Yes
dOR-37Q Early spermatids Lethal SS NROII - Not Yes Yes
Df(d se)OR-34Q Early spermatids Lethal F - Not Yes Yes
seOR-16Q Early spermatids Viable F¶ T(1;17)
pOR-13Q Late spermatids Viable FI NROII
sOR-9Q Early spermatids Juvenile F
sublethal**
sOR-12Q Early spermatocytestt Lethal F
sOR-14Q Early spermatids Lethal FI T(2;5)
dOR-5Q Stem-cell spermatogonia Juvenile F No No
lethaltt
dOR-22Q Stem-cell spermatogonia Juvenile F No No
lethaltt
pXOR-26Q§§ Stem-cell spermatogonia Viable F
pF(or bX)OR-Q¶¶ Stem-cell spermatogonia F
*Fertility of primary mutant and/or heterozygous descendants (unless shown otherwise): F, fertile; S, sterile; SS, semisterile (low litter size);
PF, poorly fertile (infrequent matings).
tOnly the c, b, and d mutations were analyzed with molecular probes. MTY811 and 23.3 are c region probes; MT4 is a b region probe; 0.3 and
94.1 are d-se region probes. -, Not done.
tIncluded as a control DNA for this particular probe; see text.
§Test not complete (TNC). Heterozygotes are -45% weight of same-sexed littermates.
IWhile the primary mutant was semisterile, semisterility subsequently segregated independently of the specific locus mutation.
IINo rearrangement was observed in karyotypes.
**Most die at 20-38 days (median, 27 days) with megacolon. Typically, pigmented areas of the fur comprise only l0%o of the surface area.
ttOr, differentiating spermatogonia.
#4Most die at or around weaning from a type of opisthotonus resembling that seen in d0P (8) homozygotes.
§§Superscript x denotes presumed allele with expression intermediate between that of marker and wild type.$$Mutant died prior to allelism test.
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are likewise summarized in Table 1, demonstrated that re-
ciprocal translocations were also segregating within the orig-
inal specific locus mutant lines. In two cases (dORI8Q and
dOR-37Q), the semisterility phenotype has not yet been genet-
ically separated from the specific locus mutation in the stock
derived from the primary mutants. A T(3;6) translocation was
observed in karyotypes from the dOR-J8Q line; no rearrange-
ments could be seen in the dOR-37Q line. In four cases(seOR-16Q, sOR-14Q, cORQ, and pOR-13Q), the semisterility
phenotype segregated independently of the specific locus
mutation; in three of these (seOR-16Q 5OR-14Q, and cOR-8Q),
translocations were detected that do not involve the chro-
mosomes in which the specific locus markers reside. Al-
though the second chromosome involved in the T(5;?) trans-
location in the COR8Q line remains to be identified, indications
are that it is not chromosome 7.
Molecular Analysis of CHL-Induced c Region Mutations.
Southern blot analysis of mutant DNA, utilizing probes
closely linked to (or, in some cases, identical to) several ofthe
loci employed as markers in the visible specific locus test,
was used to determine whether CHL can induce molecularly
detectable germ-line deletion mutations within these partic-
ular regions of the genome. Two CHL-induced c locus
mutations, cOR8Q and cOR-J5Q, were tested for deletion of
tyrosinase sequences (21) as well as of a closely linked (<0.5
cM) distal DNA sequence, 23.3 (22). Since the primary
mutants (cch*/cORQ and cch/CoR-I5Q) were not available for
study, we employed individuals heterozygous for the CHL-
induced c mutations from the breeding stock derived from a
cross of each primary mutant with a cch/CCh stock (St2A).
The MTY811 tyrosinase cDNA clone recognizes five
EcoRI fragments in mouse DNA (Fig. 1A). To determine
whether the entire tyrosinase gene [which spans >70 kb (29)]
had been deleted, carriers (cch/cOR8Q and cch/coR-sQ) of the
two CHL-induced mutations were crossed to cch/C 112K,
which carries a radiation-induced c mutation that deletes
tyrosinase, the Emv-23 integration site, and Mod-2 (refs. 9
and 22; E.M.R., unpublished results). Southern blots of
EcoRI-digested DNAs from ClI2K/COR8Q and cI2K/COR-15Q
14.5-day fetuses, along with +/+ (C3H and 101) and cch/Cch
(T and St2A) spleen DNA controls, were probed with
MTY811 and, as a positive control for hybridization, with the
chromosome 9 clone p94.1. Fig. 1A demonstrates that both
CHL-induced c mutations completely lack tyrosinase se-
quences but display the 2.3-kb chromosome 9 fragment. This
blot was then stripped and rehybridized with the c-linked
probe 23.3 (along with p94.1). Fig. 1B demonstrates that both
CHL-induced mutant c chromosomes are also deleted for the
3.7-kb EcoRI fragment detected by probe 23.3.
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b Region Mutations. DNAs from three primary mutants
carrying CHL-induced b locus mutations were analyzed in
Southern blot analysis with a 0.25-kb Pvu II subclone of
pMT4, a cDNA closely associated with, and probably iden-
tical to, the b gene itself (24). A Taq I restriction fragment (5.2
kb) detected by this Pvu II fragment is present in all chro-
mosomes carrying the standard b mutation of the mouse
fancy. All other chromosomes, including C3H and 101 (both
+b/+b), display two Taq I fragments of 4.0 and 1.2 kb (24).
Primary mutants carrying CHL-induced b mutations carry a
mutated C3H or 101 chromosome opposite a b chromosome
derived from the T stock. Consequently, Taq I-digested
DNAs from three primary CHL-induced b mutants, along
with C3H, 101, T, and two non-b CHL-induced primary
mutants (d se/Df[d se]OR34Q and d se/dOR-37Q +) were
hybridized with the Pvu II subclone of pMT4. Fig. 2 dem-
onstrates that all three primary CHL-induced b mutants carry
only the b-associated 5.2-kb Taq I fragment and are deleted
for the 4.0-kb/1.2-kb polymorphism carried in C3H, 101, and
the two d-se-region mutants.
DNAs from six homozygous b lines (b/b or b*/b*) set up
from mutant bOR-IOQ were probed with pMT4, and all were
shown to be b/b (i.e., they carried only a 5.2-kb Taq I
fragment; data not shown). If b and bOR-IOQ were transmitted
with equal frequency by the primary mutant, the probability
that all of six lines would be b/b is only 1/64. The result is,
therefore, suggestive of reduced transmission of the muta-
tion. Since no further progeny of the primary mutant are
available for test (unfortunately, bORIOQ is now extinct), the
viability/lethality of the homozygous deletion bORIOQ/
bR-'OQ will remain undetermined.
d-se Region Mutations. For this region, primary mutants
carry new d, se, or Df(d se) mutations opposite a d se
chromosome derived from the T stock. Therefore, new
CHL-induced mutations would be recovered opposite a
chromosome containing Emv-3, the provirus thought to be
responsible for the original d mutation (25, 30). In wild-type
DNA, clone pO.3, derived from the region of integration of
Emv-3 (10, 25), recognizes a 9-kb EcoRI fragment; in d DNA,
it recognizes an 18-kb fragment that represents the 9-kb
wild-type fragment plus the 9-kb integrated Emv-3 provirus.
Fig. 3A demonstrates that, of the five d-se region mutations
that were analyzed, dOR-37Q and Df(d se)OR34Q were missing
the 9-kb wild-type fragment (like the radiation-induced de-
letion mutation Df(d se)lJRl4SL [10]), indicating that they are
deleted for the pO.3 sequence. Three primary non-d-se region
mutants (b/boR-21Q, b/boR-19Q, and b/bOR-10Q), used as con-
trols, display heterozygosity for the two fragments (Fig. 3B).
Additionally, we hybridized the blot in Fig. 3A with probe
p94.1 (10). In previous analyses of radiation-induced d-se
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FIG. 1. Southern blot analysis of
CHL-induced c locus deletions. (A)
DNAs (10 ,ug) from the indicated strains
or specific genetic constructions were
digested with EcoRI, electrophoresed,
blotted, and hybridized to the mouse
tyrosinase cDNA clone MTY811 and, as
a positive control for DNA loading, the
chromosome 9 probe p94.1 (10). p94.1
detects a 2.3-kb EcoRI fragment (identi-
- 3.7 fied by the asterisk) in most mouse
DNAs. Fragment sizes (in kilobase pairs)
- 2.3 * in this and all figures were calculated by
comparison to HindIII restriction frag-
ments of phage A (data not.shown). The
8-kb EcoRI band is a doublet (29). (B) The
blot in A was stripped and reprobed with
a mixture of probe 23.3, a probe flanking
the c-linked Emv-23 integration site (22),
and p94.1.
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FIG. 2. Southern blot analysis of CHL-induced b locus muta-
tions. (A) DNAs (10 ,ug) from three primary CHL-induced b mutants
and from parental strains were digested with Taq I, electrophoresed,
blotted, and hybridized with a 250-base-pairPvu II fragment ofpMT4
(24). This probe recognizes 4.0- and 1.2-kb Taq I fragments in
wild-type DNA and a 5.2-kb fragment in b DNA. (B) DNAs (10 ,ug)
from three primary d-se region mutants, used as controls for the b
probe pMT4, were digested with Taq I and similarly hybridized.
region mutations, it was noted that some prenatally lethal d
mutations retain the pO.3 sequence but delete the sequence
p94.1, which is derived from a chromosomal region less than
1 cM proximal to d. Because there are no convenient restric-
tion fragment length polymorphisms for the 94.1 sequence,
we compared the hybridization intensity of 'the p94.1-
associated 2.3-kb EcoRI fragment with a' two-copy 3.7-kb
control fragment recognized by the chromosome 7 probe
23.3. Fig. 3B presents an example of these hybridization
profiles. Densitometric tracings from independent blots dem-
onstrated that the primary mutants d se/dORI'8Q +, d se/
dOR-37Q +, and d se/Df(d se)OR34Q carry only one copy of the
p94.1 sequence. The primary mutants d se/dOR-5Q + and d
se/dOR-22Q +, along with control DNAs C3H, 101, d +/Df(d
se)11RJ45L (10), and T, carry two copies. Consequently, three
d-se region mutations carry detectable deletions of DNA
sequences: dOR-37Q and Df(d se)0R34Q are deleted for both
pO.3 and p94.1, and doR-'18Q is deleted for p94.1 only.
DISCUSSION
Initial genetic and cytogenetic analyses of mutations recov-
ered in the visible specific locus test suggested that the
chemotherapeutic agent CHL could induce heritable dele-
tions and translocations in post-stem-cell stages of spermato-
genesis and that mutation yield from the most sensitive stage
(early spermatids) was perhaps as high as 1.3 x 1O- muta-
tions per locus per gamete (18). For CHL-exposed stem-cell
spermatogonia, the mutation yield was not significantly
greater than in controls. We have tried to generate homozy-
gotes for 14 of the 18 mutations; 9 of 11 tested post-stem-cell
mutations proved to be homozygous lethal, indicating mul-
tilocus involvement (19). The results have been further
extended by our demonstration that, at''the level of DNA
hybridization and Southern blot analysis, all of 8 tested
specific locus mutations induced in post-stem-cell stages
carry deletions of specific probe sequences within the c, b, or
d-se regions, whereas neither of the two d mutations arising
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FIG. 3. Southern blot analysis of CHL-induced d-se region
mutations. (A) DNAs (10 ,ug) were digested with EcoRI, electropho-
resed, blotted, and hybridized to the d-se region probe pO.3, which
is derived from the d-associated Emv-3 integration site (10, 25).
Included are DNAs from: the five primary mutants carrying CHL-
induced d or Df(d se) mutations; parental strains C3Hf, 101, and T;
the three primary b region mutants, as controls for heterozygosity;
and d + /Df(d se)JJR145L (10), as a control for deletion of the
wild-type 9-kb EcoRI fragment. (B) The same blot as in A on the left
was hybridized with a mixture of p94.1 (recognizing a 2.3-kb EcoRI
fragment) and, as a DNA loading control for densitometry, probe
23.3, a chromosome 7 probe (recognizing a 3.7-kb EcoRI fragment).
Note the one-copy hybridization intensity of the 2.3-kb fragment in
DNAs derived from dOR-l8Q, dOR-37Q, and Df(d se)OR'34Q compared
to two-copy parental (C3H or 101) intensity.
in spermatogonia showed detectable deletions or rearrange-
ments with available d-se region probes.
CHL mutagenesis of post-stem cells seems, moreover, to
produce germ-line deletions of substantial size. Ruppert et al.
(29) have demonstrated that the coding sequences for the
mouse tyrosinase gene extend over 70 kb of genomic DNA
sequence. Therefore, because the two CHL-induced c locus
mutations, cOR4Q and cOR-15Q, completely delete all se-
quences normally recognized by the MTY811 cDNA clone,
these deletions are at least 70 kb in size and are likely to be
larger because they also delete the closely linked 23.3 se-
quence. Moreover, the Df(d se)OR-34Q mutation is likely to be
a deletion of at least 0.16 cM in genetic length (the distance
between d and se) because it was originally recovered as a
mutant in both the d and se loci (18) and is deleted for both
the pO.3 and p94.1 sequences. Finally, perhaps most spec-
tacular is the finding (18) that bOR'9Q, a mutation induced in
mature spermatozoa and now known to delete sequences
homologous to the putative b locus clone pMT4, is a cyto-
logically visible deletion spanning chromosome bands 4C1-
4C3, inclusive.
Exposure of post-stem cells to CHL appears to induce
translocations as well as deletions. In addition to a T(X;7)
found in a p-mottled variant (18), at least four other translo-
cations were identified. All are independent of the respective
specific locus mutations. That is, each of four primary
specific locus mutants also carried an independent translo-
cation [e.g., d se/+ seORJ16Q carried a new se mutation in
chromosome 9, as well as a T(1;17) translocation]. It should
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be noted that the specific locus test does not in itself score for
translocations; these types of rearrangements are most often
detected by the phenotype of "semisterility" (low litter size)
among progeny of treated animals. For two other primary
mutants that were semisterile (d se/d0Rl37Q +, and pl
pOR-3Q), the cause of the semisterility is unknown since no
cytologically detectable rearrangements were observed.
Genetic and molecular biological studies in organisms
ranging from bacteriophage to humans have repeatedly dem-
onstrated the experimental power of utilizing genomic rear-
rangements (and particularly deletions) for the analysis of the
composition and function of whole chromosomal regions and
of specific genes within particular segments of a genome. In
the mouse system, the use of existing complexes of radiation-
induced deletion mutations available for regions surrounding
the marker loci of the visible specific locus test is facilitating
the development of fine-structure physical and functional
maps for regions of substantial size (8-11, 14, 19, 31). Indeed,
molecular access to a specific chromosomal region and quite
often to a specific gene of unknown product within a region,
can be achieved by the use of deletion mutations for the
mapping of DNA clones. Moreover, large deletions can be
used as reagents in additional rounds of mutagenesis exper-
iments for selecting N-ethyl-N-nitrosourea-induced pre-
sumed intragenic mutations that can aid in refining a regional
functional map (12). They can also be used as reagents for
simplifying the mapping of new genetic loci (especially those
defined only by lethal mutations).
N-Ethyl-N-nitrosourea currently is the most effective
known mutagen of mouse spermatogonial stem cells (32),
where it is thought to induce primarily small intragenic
changes (19, 33, 34). CHL, when applied at sensitive germ-
cell stages during the post-stem-cell period, is at least as
effective a mutagen as N-ethyl-N-nitrosourea (and much
more potent per mole of compound) and appears to produce
large lesions. The finding of eight molecularly confirmed
deletions among eight specific locus mutations induced by
CHL treatment of post-stem cells strongly suggests that CHL
can be used to induce germ-line deletion mutations (and other
chromosomal rearrangements) at a frequency that is perhaps
five times what is currently achievable with classical x-ray or
neutron treatments of male post-stem-cell stages or oocytes
(data of W. L. Russell, cited in ref. 35). Consequently, the
high frequency of induction of germ-line deletion mutations
by CHL should make possible the high-efficiency recovery of
developmentally significant variants at any locus, throughout
the genome, that are directly amenable to first-stage molec-
ular access and functional analysis.
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